masoprocol has been researched along with Leukemia, Myeloid, Acute in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seaman, WE; Woodcock, J | 1 |
| Bloch, A; Gessner, T; Wikiel, H; Zhao, L | 1 |
| Hoffbrand, AV; Khan, MA; Mehta, A; Tahami, F; Wickremasinghe, RG; Wright, F | 1 |
3 other study(ies) available for masoprocol and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Human and murine natural killer cell activity may require lipoxygenation of arachidonic acid.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Anti-Inflammatory Agents; Antibody-Dependent Cell Cytotoxicity; Antioxidants; Arachidonic Acid; Arachidonic Acids; Catechols; Cell Line; Humans; Indomethacin; Killer Cells, Natural; Leukemia, Myeloid, Acute; Masoprocol; Pyrazoles | 1984 |
Differential effect of growth- and differentiation-inducing factors on the release of eicosanoids and phospholipids from ML-1 human myeloblastic leukemia cells.
Topics: Arachidonic Acid; Caffeic Acids; Cell Differentiation; Cell Division; Eicosanoids; Humans; Hydroxyeicosatetraenoic Acids; Insulin-Like Growth Factor I; Leukemia, Myeloid, Acute; Lipoxygenase Inhibitors; Masoprocol; Phospholipids; Transferrin; Transforming Growth Factor beta; Tritium; Tumor Cells, Cultured | 1994 |
MK 886, an antagonist of leukotriene generation, inhibits DNA synthesis in a subset of acute myeloid leukaemia cells.
Topics: Adult; Aged; Child; DNA, Neoplasm; Female; Humans; Indoles; Leukemia, Myeloid, Acute; Leukotriene Antagonists; Male; Masoprocol; Middle Aged | 1993 |